Add Company
Join Now

EriVan Bio Revenue and Competitors

License our Company Data API

Alachua, FL

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • EriVan Bio's estimated annual revenue is currently $1.4M per year.(i)
  • EriVan Bio's estimated revenue per employee is $155,000

Employee Data

  • EriVan Bio has 9 Employees.(i)
  • EriVan Bio grew their employee count by 80% last year.

EriVan Bio's People

NameTitleEmail/Phone
1
Scientific AdvisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is EriVan Bio?

EriVan Bio is a biotechnology company, established to innovate and deliver products and services related to exosome technology for molecular and cell biology research and therapeutic purposes, particularly regenerative medicine and cancer treatment. EriVan Bio is focused on the development of a broad pipeline of novel and targeted biomolecules to address different unmet medical needs. EriVan Bio works mainly in the therapeutic and drug development field and on exosome-based diagnostics to develop exosome-based tests and assays for unmet medical needs. Moreover, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to cancer cells, for example, delivering a small interfering RNA specific for a particular oncogene expressed in a tumor cell. Research tools for exosome detection and isolation constitute another field of expertise and development.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.4M

Revenue (est)

80%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M9-25%N/A
#2
$1.6M100%N/A
#3
$1.9M12-8%N/A
#4
$2.8M186%N/A
#5
$3.6M18-18%N/A